It’s rare to find a consumer based product that is backed by real science.
I’ve been an avid follower of Richard Spragues (CEO of AI-based healthcare company Airdoc Technology Inc and microbiome experimenter) work for some years now and recently had the great privilege of interviewing him on what first sparked his interest in the microbiome, human DNA vs. microbiome testing, how he imagines the world of microbiome and precision medicine will change over the next 5 years and his own experience using DayTwo.
You can get cheap DNA testing from several companies, but that’s only showing a very high level of what’s going on in the microbiome and there are some interesting things you can learn. But if you want to do something that’s more actionable, the (higher resolution sequencing that DayTwo provides) is much more interesting.
Richard talks about some of the “non obvious, but actionable” surprises he discovered doing the DayTwo test, alongside testing his blood glucose levels with a Continuous Glucose Monitor (CGM). His long-time breakfast of oatmeal that he thought to be extremely healthy was actually quite detrimental for his glucose levels. However, the app helped him tweak this breakfast by adding a small amount of butter to transform his meal into an excellent option for avoiding glucose spikes and drops.
Let us know if you would like to be interviewed by shooting us an email